Home Applications 206510 Application 206510
Type NDA
Sponsor MERCK SHARP DOHME Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DUTREBIS LAMIVUDINE; RALTEGRAVIR POTASSIUM TABLET;ORAL 150MG;EQ 300MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206510-001 DUTREBIS LAMIVUDINE; RALTEGRAVIR POTASSIUM 150MG;EQ 300MG BASE TABLET / ORAL 2015-02-06
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 N206510-001 7754731*PED 2029-09-11 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N206510-001 DUTREBIS 150MG;EQ 300MG BASE TABLET / ORAL 2015-02-06 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N206510-001 DUTREBIS 150MG;EQ 300MG BASE TABLET / ORAL 2015-02-06 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N206510-001 DUTREBIS 150MG;EQ 300MG BASE TABLET / ORAL 2015-02-06 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N206510-001 DUTREBIS 150MG;EQ 300MG BASE TABLET / ORAL 2015-02-06 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 7 · 255 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206510-001 7754731*PED 2029-09-11 Pediatric extension c2088c7a36db…2026-09-14 22:38:34 2026-08 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206510-001 7754731*PED 2029-09-11 Pediatric extension 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206510-001 7754731*PED 2029-09-11 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206510-001 7754731*PED 2029-09-11 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206510-001 7754731*PED 2029-09-11 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206510-001 7754731*PED 2029-09-11 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206510-001 7754731*PED 2029-09-11 Pediatric extension fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206510-001 7754731*PED 2029-09-11 Pediatric extension b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206510-001 7169780*PED 2024-04-03 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206510-001 7754731*PED 2029-09-11 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206510-001 7169780*PED 2024-04-03 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206510-001 7754731*PED 2029-09-11 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206510-001 7169780*PED 2024-04-03 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206510-001 7754731*PED 2029-09-11 Pediatric extension 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206510-001 7169780*PED 2024-04-03 Pediatric extension d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206510-001 7754731*PED 2029-09-11 Pediatric extension d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206510-001 7169780*PED 2024-04-03 Pediatric extension d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206510-001 7754731*PED 2029-09-11 Pediatric extension d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206510-001 7169780*PED 2024-04-03 Pediatric extension 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206510-001 7754731*PED 2029-09-11 Pediatric extension 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206510-001 7169780*PED 2024-04-03 Pediatric extension 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206510-001 7754731*PED 2029-09-11 Pediatric extension 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206510-001 7169780*PED 2024-04-03 Pediatric extension 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206510-001 7754731 2029-03-11 U-1663 Drug substance, Drug product 2015-03-04 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206510-001 7754731*PED 2029-09-11 Pediatric extension 1e350fbaab3a…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 44946 ORIG 2016-04-11 23023 ORIG 2016-04-11 10576 ORIG 2015-02-12 40554 ORIG 2015-02-10 63111 ORIG 1900-01-01 63110 ORIG 1900-01-01